Bulletin
Investor Alert

New York Markets After Hours

CareDx Inc.

NAS: CDNA

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

May 26, 2020, 5:21 p.m.

/zigman2/quotes/200138382/composite

$

30.25

Change

+0.08 +0.27%

Volume

Volume 169,774

Quotes are delayed by 20 min

/zigman2/quotes/200138382/composite

Today's close

$ 31.39

$ 30.17

Change

-1.22 -3.89%

Day low

Day high

$30.12

$32.32

Open

52 week low

52 week high

$13.04

$41.27

Open

Company Description

CareDx, Inc. operates as a transplant diagnostics company,which discovers, develops, and commercializes diagnostic solutions. Its product includes AlloMap, AlloSure, and Laboratory products. The company was founded on December 21, 1998 and is headquartered in Brisbane, CA.

Valuation

Price to Sales Ratio

7.16

Price to Book Ratio

9.26

Enterprise Value to EBITDA

-61.96

Enterprise Value to Sales

8.18

Total Debt to Enterprise Value

0.00

Efficiency

Revenue/Employee

329,192.00

Income Per Employee

-56,912.00

Receivables Turnover

7.52

Total Asset Turnover

0.87

Liquidity

Current Ratio

2.07

Quick Ratio

1.89

Cash Ratio

1.10

Profitability

Gross Margin

63.20

Operating Margin

-18.83

Pretax Margin

-18.85

Net Margin

-17.29

Return on Assets

-15.02

Return on Equity

-22.54

Return on Total Capital

-24.10

Return on Invested Capital

-22.50

Capital Structure

Total Debt to Total Equity

3.33

Total Debt to Total Capital

3.22

Total Debt to Total Assets

2.08

Long-Term Debt to Equity

0.07

Long-Term Debt to Total Capital

0.07

Officers and Executives

Name Age Officer Since Title
Dr. Peter K. Maag 52 2012 Chief Executive Officer & Director
Dr. Reginald Seeto 47 2018 President & Chief Business Officer
Mr. Paul Ciccolella - 2018 Senior Vice President-Global Operations
Mr. Michael Bell 50 2017 Chief Financial & Principal Accounting Officer
Dr. Amitabh Shukla - 2019 Senior Vice President-Technology

Insider Actions

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
05/19/2020 Peter K. Maag
Chief Executive Officer; Director
30,000   Disposition at $32.24 per share. 967,200
05/13/2020 George W. Bickerstaff
Director
10,000   Disposition at $27.65 per share. 276,500
05/11/2020 Michael D. Goldberg
Director
10,000   Disposition at $29.86 per share. 298,600
05/06/2020 Michael Bell
Chief Financial Officer
1,429   Disposition at $29.58 per share. 42,269
05/06/2020 Michael Bell
Chief Financial Officer
55,707   Disposition at $28.99 per share. 1,614,945
05/06/2020 William A. Hagstrom
Director
15,000   Disposition at $29.12 per share. 436,800
05/06/2020 Michael Bell
Chief Financial Officer
11,458   Derivative/Non-derivative trans. at $12.24 per share. 140,245
05/06/2020 Michael Bell
Chief Financial Officer
3,211   Derivative/Non-derivative trans. at $6.31 per share. 20,261
05/06/2020 Michael Bell
Chief Financial Officer
1,667   Derivative/Non-derivative trans. at $2.8 per share. 4,667
05/06/2020 Michael Bell
Chief Financial Officer
10,313   Derivative/Non-derivative trans. at $5.9 per share. 60,846
05/06/2020 Michael Bell
Chief Financial Officer
9,167   Derivative/Non-derivative trans. at $1 per share. 9,167
05/06/2020 William A. Hagstrom
Director
15,000   Derivative/Non-derivative trans. at $1.22 per share. 18,300
03/16/2020 Peter K. Maag
Chief Executive Officer; Director
10,000   Disposition at $17.39 per share. 173,900
03/03/2020 Ralph D. Snyderman
Director
14,598   Derivative/Non-derivative trans. at $3.7 per share. 54,012
02/27/2020 Peter K. Maag
Chief Executive Officer; Director
48,000   Award at $0 per share. 0
02/27/2020 Reginald Seeto
See Remarks
16,000   Award at $0 per share. 0
02/27/2020 Michael Bell
Chief Financial Officer
16,000   Award at $0 per share. 0
02/27/2020 Sasha King
Chief Commercial Officer
8,000   Award at $0 per share. 0
02/27/2020 Reginald Seeto
See Remarks
5,296   Derivative/Non-derivative trans. at $22.44 per share. 118,842
02/27/2020 Michael Bell
Chief Financial Officer
5,532   Derivative/Non-derivative trans. at $22.44 per share. 124,138
02/27/2020 Sasha King
Chief Commercial Officer
2,766   Derivative/Non-derivative trans. at $22.44 per share. 62,069
02/18/2020 Peter K. Maag
Chief Executive Officer; Director
10,000   Disposition at $26.62 per share. 266,200
02/14/2020 Sasha King
Chief Commercial Officer
7,390   Disposition at $26.01 per share. 192,213
02/03/2020 Peter K. Maag
Chief Executive Officer; Director
40,000   Award at $0 per share. 0
02/03/2020 Reginald Seeto
See Remarks
20,000   Award at $0 per share. 0
02/03/2020 Michael Bell
Chief Financial Officer
15,000   Award at $0 per share. 0
02/03/2020 Sasha King
Chief Commercial Officer
8,000   Award at $0 per share. 0
/news/latest/company/us/cdna

MarketWatch News on CDNA

  1. Charting a bull-trend pullback, S&P 500 nails first support (2,873)

    11:28 a.m. June 13, 2019

    - Michael Ashbaugh

  2. CareDx stock price target raised to $46 from $38 at Raymond James

    9:20 a.m. March 22, 2019

    - Tomi Kilgore

  3. Harry Boxer’s four stocks to watch this week

    2:46 p.m. Nov. 1, 2018

    - Harry Boxer

  4. CareDX stock soars nearly 20% after earnings

    7:40 p.m. Aug. 9, 2018

    - Max A. Cherney

  5. CareDx stock price target raised to $10 from $8 at Raymond James

    8:50 a.m. March 23, 2018

    - Tomi Kilgore

  6. Lowe’s Is Adding Three New Directors to Board

    12:15 a.m. Jan. 27, 2018

    - Barron's Online

  7. Activist Starboard Value Squares Up Its Position in Monotype

    12:55 a.m. Oct. 14, 2017

    - Barron's Online

  8. CareDx upgraded to outperform from market perform at Raymond James

    7:58 a.m. Sept. 27, 2017

    - Tomi Kilgore

  9. Almost half of venture-backed IPOs this year are losers

    6:00 a.m. Oct. 3, 2014

    - Philip van Doorn

/news/nonmarketwatch/company/us/cdna

Other News on CDNA

  1. CareDx, Inc 2020 Q1 - Results - Earnings Call Presentation

    2:08 p.m. May 1, 2020

    - Seeking Alpha

  2. CareDx (CDNA) Reports Break-Even Earnings for Q1

    8:15 p.m. April 30, 2020

    - Zacks.com

  3. 10-Q: CAREDX, INC.

    5:23 p.m. April 30, 2020

    - Edgar Online - (EDG = 10Q, 10K)

  4. Notable earnings after Thursday's close

    5:35 p.m. April 29, 2020

    - Seeking Alpha

  5. CareDx Q1 2020 Earnings Preview

    5:35 p.m. April 29, 2020

    - Seeking Alpha

  6. CareDx: A Robust Transplant Diagnostics Pick For 2020

    4:47 p.m. April 23, 2020

    - Seeking Alpha

  7. CareDx Inc (CDNA) Investor Presentation - Slideshow

    3:12 p.m. March 5, 2020

    - Seeking Alpha

  8. 10-K: CAREDX, INC.

    7:07 a.m. Feb. 28, 2020

    - Edgar Online - (EDG = 10Q, 10K)

  9. CareDx Q4 2019 Earnings Preview

    6:35 p.m. Feb. 26, 2020

    - Seeking Alpha

  10. Notable earnings after Thursday's close

    6:35 p.m. Feb. 26, 2020

    - Seeking Alpha

  11. CareDx (CDNA) Upgraded to Strong Buy: Here's Why

    1:00 p.m. Feb. 7, 2020

    - Zacks.com

  12. US Service Sector Accelerates in January: 5 Stocks to Buy

    10:16 a.m. Feb. 6, 2020

    - Zacks.com

  13. Loading more headlines...

At a Glance

CareDx, Inc.

1 Tower Place

South San Francisco, California 94080

Phone

1 4152872300

Industry

Healthcare Provision

Sector

Health Care/Life Sciences

Fiscal Year-end

12/2020

Revenue

$127.07M

Net Income

$-21.97M

2019 Sales Growth

66.0%

Employees

386.00

/news/pressrelease/company/us/cdna

Press Releases on CDNA

  1. Coronavirus Impact on Transplant Diagnostics Market

    10:17 a.m. May 20, 2020

    - Heraldkeepers

  2. CareDx's AlloSeq Tx 17 Awarded CE Mark Approval

    7:00 a.m. May 15, 2020

    - GlobeNewswire

  3. CareDx's AlloSeq Tx 17 Awarded CE Mark Approval

    7:00 a.m. May 15, 2020

    - GlobeNewswire

  4. CareDx Brings the Transplant Patient Community Together

    7:01 a.m. May 7, 2020

    - GlobeNewswire

  5. CareDx Brings the Transplant Patient Community Together

    7:00 a.m. May 7, 2020

    - GlobeNewswire

  6. CareDx Reports First Quarter 2020 Results

    4:47 p.m. April 30, 2020

    - GlobeNewswire

  7. CareDx Reports First Quarter 2020 Results

    4:06 p.m. April 30, 2020

    - GlobeNewswire

  8. CareDx Engages European Lab Community in Virtual Meetings

    8:25 a.m. April 27, 2020

    - GlobeNewswire

  9. CareDx Engages European Lab Community in Virtual Meetings

    8:25 a.m. April 27, 2020

    - GlobeNewswire

  10. CareDx and Johns Hopkins Partner on AlloSure Lung Surveillance

    7:03 a.m. April 23, 2020

    - GlobeNewswire

  11. CareDx and Johns Hopkins Partner on AlloSure Lung Surveillance

    7:01 a.m. April 23, 2020

    - GlobeNewswire

  12. Loading more headlines...
Link to MarketWatch's Slice.